Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
Blood|January 8, 2020
Exteriorisation of Mannoses on Human Erythrocyte Membrane Skeleton Provides 'Eat Me' Signals for Oxidatively Damaged Cells to be Cleared By Macrophages: A Pathway Mediating Hemolysis in Sickle Cell DiseaseMark A Vickers, Robert N Barker, Huan Cao, et al.
Human Molecular Genetics|April 21, 2009
Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotidesLoren G Fong, Timothy A Vickers, Emily A Farber, et al.
The Journal of Clinical Investigation|March 3, 2006
Prelamin A and lamin A appear to be dispensable in the nuclear laminaLoren G Fong, Jennifer K Ng, Jan Lammerding, et al.
European Journal of Human Genetics : EJHG|April 21, 2001
Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effectsS W Horsley, R J Daniels, E Anguita, et al.
Frontiers in Immunology|July 16, 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulationRachel S Cooper, Catherine Sutherland, Linda M Smith, et al.
Journal of Medicinal Chemistry|April 28, 2010
Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissueEdward V Wancewicz, Martin A Maier, Andrew M Siwkowski, et al.
Harm Reduction Journal|May 19, 2026
A mixed methods examination of organizational approaches to fentanyl test strip distribution and training across multiple statesKitty H Gelberg, Megan E Hall, Janet E Childerhose, et al.
The Journal of Experimental Medicine|April 15, 2015
Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axisMiguel F Diaz, Nan Li, Hyun Jung Lee, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2Gang Ye, Joseph P Gallant, Christopher Massey, et al.
Nature Biotechnology|May 1, 2019
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic indexWen Shen, Cheryl L De Hoyos, Michael T Migawa, et al.
Pageof 30